Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 13 Endometrial Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Breast Neoplasms 4 Neoplasms 3 Uterine Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Melanoma 1 Laryngeal Neoplasms 1 Kenny-Caffey syndrome, Type 1 1 Hyperglycemia 1 High Grade Serous Ovarian Cancer 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Fallopian Tube Neoplasms 1

Interventions

Fluorouracil 80 Oxaliplatin 72 Leucovorin 66 Irinotecan 60 Capecitabine 58 Bevacizumab 57 Cetuximab 43 Folfox protocol 22 Drug Therapy 22 Neoadjuvant Therapy 19 HMPL-013 17 Colonoscopy 17 regorafenib 15 apatinib 11 Panitumumab 11 Chemotherapy, Adjuvant 11 trifluridine tipiracil drug combination 10 XELOX 10 Laparoscopy 10 IFL protocol 10 sintilimab 9 raltitrexed 9 Radiotherapy 9 Blood Specimen Collection 9 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 tislelizumab 7 pembrolizumab 7 Endoscopic Mucosal Resection 7 Aspirin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × olaparib × Clear all

NCT05201612 2023-02-24

PEMBROLA

Grupo Espanol Multidisciplinario del Cancer Digestivo

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡